Literature DB >> 31414959

Influence of dietary inorganic nitrate on blood pressure and vascular function in hypertension: prospective implications for adjunctive treatment.

Ryan M Broxterman1,2, D Taylor La Salle3, Jia Zhao2, Van R Reese2, Russell S Richardson1,2,3,4, Joel D Trinity1,2,3,4.   

Abstract

Dietary inorganic nitrate (nitrate) is a promising adjunctive treatment to reduce blood pressure and improve vascular function in hypertension. However, it remains unknown if the efficacy of nitrate is dependent upon an elevated blood pressure or altered by medication in patients with hypertension. Therefore, blood pressure and vascular function, measured by passive leg movement (PLM) and flow-mediated dilation (FMD), were assessed following 3 days of placebo (nitrate-free beetroot juice) and nitrate (nitrate-rich beetroot juice) administration in 13 patients (age: 53 ± 12 yr) with hypertension taking antihypertensive medications (study 1) and in 14 patients (49 ± 13 yr) with hypertension not taking antihypertensive medications (study 2). In study 1, plasma nitrite concentration was greater for nitrate than placebo (341 ± 118 vs. 308 ± 123 nmol/L, P < 0.05), yet blood pressure and vascular function were unaltered. In study 2, plasma nitrite concentration was greater for nitrate than placebo (340 ± 102 vs. 295 ± 93 nmol/L, P < 0.01). Systolic (136 ± 16 vs. 141 ± 19 mmHg), diastolic (84 ± 13 vs. 88 ± 12 mmHg), and mean (101 ± 12 vs. 106 ± 13 mmHg) blood pressures were lower (P < 0.05), whereas the PLM change in leg vascular conductance (6.0 ± 3.0 vs. 5.1 ± 2.6 mL·min-1·mmHg-1) and FMD (6.1 ± 2.4% vs. 4.1 ± 2.7%) were greater (P < 0.05) for nitrate than placebo. The changes in systolic blood pressure (r = -0.60) and FMD (r = -0.48) induced by nitrate were inversely correlated (P < 0.05) to the respective baseline values obtained in the placebo condition. Thus, the efficacy of nitrate to improve blood pressure and vascular function in hypertension appears to be dependent on the degree of blood pressure elevation and vascular dysfunction and not antihypertensive medication status, per se.NEW & NOTEWORTHY Dietary nitrate (nitrate) is a promising intervention to improve blood pressure and vascular function in hypertension. We demonstrate that these beneficial effects of nitrate are inversely related to the baseline value in a continuous manner with no distinction between antihypertensive medication status. Thus, the efficacy of nitrate to improve blood pressure and vascular function in hypertension appears to be dependent on the degree of blood pressure elevation and vascular dysfunction and not antihypertensive mediation status.

Entities:  

Keywords:  flow-mediated dilation; passive leg movement; vascular dysfunction

Mesh:

Substances:

Year:  2019        PMID: 31414959      PMCID: PMC6850980          DOI: 10.1152/japplphysiol.00371.2019

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  44 in total

1.  Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III.

Authors:  S S Franklin; M J Jacobs; N D Wong; G J L'Italien; P Lapuerta
Journal:  Hypertension       Date:  2001-03       Impact factor: 10.190

2.  The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT).

Authors:  Walter T Ambrosius; Kaycee M Sink; Capri G Foy; Dan R Berlowitz; Alfred K Cheung; William C Cushman; Lawrence J Fine; David C Goff; Karen C Johnson; Anthony A Killeen; Cora E Lewis; Suzanne Oparil; David M Reboussin; Michael V Rocco; Joni K Snyder; Jeff D Williamson; Jackson T Wright; Paul K Whelton
Journal:  Clin Trials       Date:  2014-06-05       Impact factor: 2.486

3.  Ultrasound assessment of flow-mediated dilation.

Authors:  Ryan A Harris; Steven K Nishiyama; D Walter Wray; Russell S Richardson
Journal:  Hypertension       Date:  2010-03-29       Impact factor: 10.190

4.  Efficacy and Safety of Firibastat, A First-in-Class Brain Aminopeptidase A Inhibitor, in Hypertensive Overweight Patients of Multiple Ethnic Origins.

Authors:  Keith C Ferdinand; Fabrice Balavoine; Bruno Besse; Henry R Black; Stephanie Desbrandes; Howard C Dittrich; Shawna D Nesbitt
Journal:  Circulation       Date:  2019-04-24       Impact factor: 29.690

5.  Dietary nitrate supplementation alters the oral microbiome but does not improve the vascular responses to an acute nitrate dose.

Authors:  Mia Burleigh; Luke Liddle; David J Muggeridge; Christopher Monaghan; Nicholas Sculthorpe; John Butcher; Fiona Henriquez; Chris Easton
Journal:  Nitric Oxide       Date:  2019-04-30       Impact factor: 4.427

6.  Enhanced vasodilator activity of nitrite in hypertension: critical role for erythrocytic xanthine oxidoreductase and translational potential.

Authors:  Suborno M Ghosh; Vikas Kapil; Isabel Fuentes-Calvo; Kristen J Bubb; Vanessa Pearl; Alexandra B Milsom; Rayomand Khambata; Sheiva Maleki-Toyserkani; Mubeen Yousuf; Nigel Benjamin; Andrew J Webb; Mark J Caulfield; Adrian J Hobbs; Amrita Ahluwalia
Journal:  Hypertension       Date:  2013-04-15       Impact factor: 10.190

7.  Regulation of free radical outflow from an isolated muscle bed in exercising humans.

Authors:  Damian M Bailey; Ian S Young; Jane McEneny; Lesley Lawrenson; Jeannie Kim; Jeremy Barden; Russell S Richardson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-05-20       Impact factor: 4.733

8.  Passive leg movement and nitric oxide-mediated vascular function: the impact of age.

Authors:  Joel D Trinity; H Jonathan Groot; Gwenael Layec; Matthew J Rossman; Stephen J Ives; David E Morgan; Ben S Gmelch; Amber Bledsoe; Russell S Richardson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-01-09       Impact factor: 4.733

9.  Physiological role for nitrate-reducing oral bacteria in blood pressure control.

Authors:  Vikas Kapil; Syed M A Haydar; Vanessa Pearl; Jon O Lundberg; Eddie Weitzberg; Amrita Ahluwalia
Journal:  Free Radic Biol Med       Date:  2012-11-23       Impact factor: 7.376

10.  Dietary nitrate provides sustained blood pressure lowering in hypertensive patients: a randomized, phase 2, double-blind, placebo-controlled study.

Authors:  Vikas Kapil; Rayomand S Khambata; Amy Robertson; Mark J Caulfield; Amrita Ahluwalia
Journal:  Hypertension       Date:  2014-11-24       Impact factor: 10.190

View more
  7 in total

1.  Dietary nitrate supplementation and small muscle mass exercise hemodynamics in patients with essential hypertension.

Authors:  Ryan M Broxterman; D Taylor La Salle; Jia Zhao; Van R Reese; Oh Sung Kwon; Russell S Richardson; Joel D Trinity
Journal:  J Appl Physiol (1985)       Date:  2022-07-14

2.  Dietary Inorganic Nitrate/Nitrite Supplementation Reduces Central and Peripheral Blood Pressure in Patients With Type 2 Diabetes Mellitus.

Authors:  Joshua M Bock; William E Hughes; Kenichi Ueda; Andrew J Feider; Satoshi Hanada; Darren P Casey
Journal:  Am J Hypertens       Date:  2022-09-01       Impact factor: 3.080

3.  The Effect of Chinese Herbal Medicine Combined With Western Medicine on Vascular Endothelial Function in Patients With Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Weiquan Ren; Miyuan Wang; Jiangquan Liao; Lingling Li; Deshuang Yang; Ruiqi Yao; Li Huang
Journal:  Front Pharmacol       Date:  2020-06-16       Impact factor: 5.810

4.  Nitrate Derived From Beetroot Juice Lowers Blood Pressure in Patients With Arterial Hypertension: A Systematic Review and Meta-Analysis.

Authors:  Cicero Jonas R Benjamim; Andrey Alves Porto; Vitor Engrácia Valenti; Andressa Crystine da Silva Sobrinho; David M Garner; Bruno Gualano; Carlos Roberto Bueno Júnior
Journal:  Front Nutr       Date:  2022-03-15

5.  Effect of beetroot or beetroot plus vitamin C supplementation on cardiovascular function in patients with coronary artery disease: protocol for a double-blind, placebo-controlled, randomised trial.

Authors:  Leila Sadat Bahrami; Mohsen Mohebaty; Seyyed Mostafa Arabi; Hamed Tabesh; Mohsen Nematy; Reza Rezvani
Journal:  BMJ Open       Date:  2022-06-16       Impact factor: 3.006

6.  Endogenous Hemoprotein-Dependent Signaling Pathways of Nitric Oxide and Nitrite.

Authors:  Matthew R Dent; Anthony W DeMartino; Jesús Tejero; Mark T Gladwin
Journal:  Inorg Chem       Date:  2021-07-27       Impact factor: 5.436

Review 7.  Exogenous NO Therapy for the Treatment and Prevention of Atherosclerosis.

Authors:  Tommaso Gori
Journal:  Int J Mol Sci       Date:  2020-04-13       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.